Utility of the adverse outcome pathway concept in drug development

Expert Opinion on Drug Metabolism and Toxicology

Volumn 13, Issue 1, 2017, Pages 1-3

  Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

chemicals; hazard; mechanistic toxicology; omics technologies; Toxicology for the 21st century

Indexed keywords

ADVERSE OUTCOME; DRUG DEVELOPMENT; DRUG MONITORING; EDITORIAL; HIGH THROUGHPUT SCREENING; METABOLOMICS; PRACTICE GUIDELINE; TRANSCRIPTOMICS; DRUG DESIGN; HUMAN; PROCEDURES; RISK ASSESSMENT; TOXICITY TESTING;

DRUG DESIGN; HUMANS; RISK ASSESSMENT; TOXICITY TESTS;

EID: 84992161916     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1080/17425255.2017.1246535     Document Type: Editorial

References (16)

1. USA National Research Council/National Academy of Sciences in 2007. Toxicity Testing in the 21st Century:A Vision and a Strategy. Available from:http://www.nap.edu/catalog/11970/toxicity-testing-in-the-21st-century-avision-and-a.
2. Hartung T, McBride M., Food for thought … on mapping the human toxome. ALTEX. 2011;28(2):83–93.
3. Kleensang A, Maertens A, Rosenberg M, et al. T4 workshop report:pathways of toxicity. ALTEX. 2014 Jan 1;31(1):53–61.• Multi-stakeholder workshop report defining the PoT concept.
4. Bouhifd M, Andersen ME, Baghdikian C, et al. The Human Toxome project. ALTEX. 2015;32(2):112–124.
5. Tollefsen KE, Scholz S, Cronin MT, et al. Applying adverse outcome pathways (AOPs) to support integrated approaches to testing and assessment (IATA). Regulat Toxicol Pharmacol. 2014;70:629–640.• Multi-stakeholder report on use of AOP for constructing testing strategies.
6. Hartung T, Luechtefeld T, Maertens A, et al. Integrated testing strategies for safety assessments. ALTEX. 2013;30(1):3–18.
7. Hartung T, van Vliet E, Jaworska J, et al. Food for thought–systems toxicology. ALTEX. 2012;29(2):119–128.•• Concept article laying out the challenges and opportunities of systems toxicology.
8. Hartung T. Food for thought … on animal tests. ALTEX. 2008;25(1):3–16.
9. Hartung T. Food for thought … on cell culture. ALTEX. 2007;24(3):143–152.
10. Bouhifd M, Hartung T, Hogberg HT, et al. Review:toxicometabolomics. J Appl Toxicol. 2013;33(12):1365–1383.
11. Ramirez T, Daneshian M, Kamp H, et al. Metabolomics in toxicology and preclinical research. ALTEX. 2013;30(2):209–225.
12. Bouhifd M. Quality assurance of metabolomics. ALTEX. 2015;32(4):319–326.
13. Maertens A, Luechtefeld T, Kleensang A, et al. MPTP’s pathway of toxicity indicates central role of transcription factor SP1. Arch Toxicol. Springer Berlin Heidelberg. 2015;89(5):743–775.
14. Maertens A, Bouhifd M, Zhao L, et al. Metabolomic network analysis of estrogen-stimulated MCF-7 cells:a comparison of overrepresentation analysis, quantitative enrichment analysis and pathway analysis versus metabolite network analysis. Arch Toxicol. 2016 Apr 2. published online. DOI:10.1007/s00204-016-1695-x
15. Rovida C, Asakura C, Daneshian M, et al. Toxicity testing in the 21st century beyond environmental chemicals. ALTEX. 2015;32(1):25–40.•• Concept article based on a multi-stakeholder workshop laying out the topic of this editorial.
16. Hartung T, Hoffmann S, Stephens M. Mechanistic validation. ALTEX. 2013;30(2):119–130.